ViGenCell wins ASCO oral slot with Phase 2 cell therapy data

--------------------------------------------------------------------
Source: The Korea Herald
Published: 2026-04-22 12:13 UTC+10:00
Section: All News
Factuality Score: 100
Opinion Category: Neutral
Topics: South Korea, World News
--------------------------------------------------------------------
Snippet:
ViGenCell has been selected to deliver an official oral presentation at this year’s American Society of Clinical Oncology annual meeting next month, becoming the first Korean company to do so regarding clinical studies of a cell therapy.
--------------------------------------------------------------------
>>> Read full article at The Korea Herald <<<
<-- Back to Home
< >
[Close]